Dexco planned BRL 38.10 million transfer: what it means for Dexco stock

Published on 10/14/2026 at 03:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dexco seeks 1.058 billion authorized shares from 920 million at the October 26 vote. Dexco stock has 919.034 million shares outstanding.

Asset transfer and shareholder vote

Dexco announced a BRL 38.10 million asset transfer on October 6, 2026.
Second-quarter revenue reached BRL 2.232 billion on August 11, 2026.
Shareholders vote on October 26, 2026, followed by third-quarter results on November 4, 2026.

Dexco, BRDXCOACNOR8, Illustration mit AI erstellt.

Dexco (BRDXCOACNOR8) planned a BRL 38.10 million transfer of forestry and real estate assets on October 6, 2026. The move would place assets from wholly owned Duratex Florestal directly at the parent company for operating use and potential financing, according to Brazil Stock Guide. The central investor question is whether the reorganization improves financial flexibility without changing the share capital structure.

Three steps in Dexco financial strategy

In December 2025, Dexco's share capital rose to BRL 4.37 billion after a reserve capitalization and bonus share distribution, as Brazil Stock Guide reported. On August 11, 2026, the second-quarter review cited revenue of BRL 2.232 billion and adjusted recurring EBITDA of BRL 547.40 million, up 23.60 percent from the prior-year quarter, according to TraderNews. On October 6, 2026, the proposed BRL 38.10 million transfer became the latest step in that balance-sheet strategy.

What the transfer means for capital use

The proposed portfolio includes BRL 19.30 million in biological assets and BRL 21.40 million in real estate, offset by BRL 2.60 million in deferred tax liabilities. The resulting net book value is BRL 38.10 million, and the company said the structure is intended to improve the financial use of the assets and administrative efficiency.

The same shareholder meeting will consider raising the authorized share ceiling to 1.058 billion common shares from 920 million. Dexco has 919.034 million shares outstanding, but the proposal does not itself issue new shares or dilute existing holders because Duratex Florestal is wholly owned by Dexco.

Dates that shape the next decision

Dexco's extraordinary general meeting is scheduled for October 26, 2026, to vote on the partial spin-off and asset incorporation, as Brazil Stock Guide reported. The next quarterly results are scheduled for November 4, 2026, with a results conference listed for November 5, 2026, according to TraderNews.

The next capital decision

The October 26 vote will test whether Dexco can centralize assets and restore authorized-share capacity while keeping the current capital structure unchanged. The November 4 results will provide the next quantified check on revenue, margins and leverage.